-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 11, the marketing application of levalbuterol hydrochloride atomized inhalation solution submitted by Hunan Huana Pharmaceutical .
Figure 1: The latest product status of Warner Br.
Source: CDE official website
Levosalbutamol is an adrenergic beta-receptor agonist, salbutamol levorotatory body, has the effect of relaxing bronchial smooth muscle, and clinically can be used for the treatment or prevention of bronchospasm caused by reversible airway obstructive diseas.
Levosalbutamol inhalation solution was originally developed by Sepracor I.
According to data from Min.
Figure 2: Sales of levalbuterol hydrochloride atomized inhalation solution at terminals in public medical institutions in China (unit: 10,000 yuan)
Source: Min.
In addition to the original research GSK and health yuan, there are also Jiangsu Changtai Pharmaceutical, Sipu Ruite, Jiangsu Dahongying, and Yangzhou Zhongbao Pharmaceutical that have been approved to produce levalbuterol hydrochloride atomized inhalation soluti.
Source: CDE official website, Minet database, e.